CD19 and neoplasm: The obtained data indicate a partial cytolysis of CD19+ tumor cells and correlate with previously published results by Guedan et al., in which the effect of CAR-T cells on non–small cell lung carcinoma (L55) cells was assessed in real-time via the xCELLigence system [12].